Article info
Original article
Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
- Correspondence to Professor Nicoline Hoogerbrugge, 849 Human Genetics, Radboud University Nijmegen Medical Centre, Postbox 9101, 6500 HB Nijmegen, The Netherlands; n.hoogerbrugge{at}antrg.umcn.nl
Citation
Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
Publication history
- Received January 11, 2010
- Revised February 9, 2010
- Accepted February 11, 2010
- First published June 30, 2010.
Online issue publication
June 30, 2010
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.